Wellington Management Group LLP Sells 36,171 Shares of Progyny, Inc. (NASDAQ:PGNY)

Wellington Management Group LLP lowered its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 8.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 394,129 shares of the company's stock after selling 36,171 shares during the quarter. Wellington Management Group LLP owned about 0.46% of Progyny worth $6,799,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Voya Investment Management LLC increased its position in Progyny by 1.4% during the fourth quarter. Voya Investment Management LLC now owns 51,792 shares of the company's stock worth $893,000 after acquiring an additional 701 shares during the period. Signaturefd LLC increased its position in Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after acquiring an additional 1,355 shares during the period. KBC Group NV increased its position in Progyny by 84.6% during the fourth quarter. KBC Group NV now owns 4,669 shares of the company's stock worth $81,000 after acquiring an additional 2,140 shares during the period. F M Investments LLC increased its position in Progyny by 13.0% during the fourth quarter. F M Investments LLC now owns 20,420 shares of the company's stock worth $352,000 after acquiring an additional 2,342 shares during the period. Finally, Entropy Technologies LP increased its position in Progyny by 5.5% during the fourth quarter. Entropy Technologies LP now owns 47,883 shares of the company's stock worth $826,000 after acquiring an additional 2,499 shares during the period. Institutional investors own 94.93% of the company's stock.

Progyny Stock Performance

Shares of NASDAQ:PGNY traded up $0.32 on Friday, hitting $21.68. The stock had a trading volume of 509,321 shares, compared to its average volume of 1,710,718. Progyny, Inc. has a twelve month low of $13.39 and a twelve month high of $30.42. The firm's 50 day moving average price is $22.02 and its 200-day moving average price is $20.35. The company has a market capitalization of $1.86 billion, a price-to-earnings ratio of 37.38, a price-to-earnings-growth ratio of 2.39 and a beta of 1.37.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $324.04 million during the quarter, compared to analyst estimates of $307.86 million. During the same quarter in the prior year, the firm posted $0.17 EPS. The firm's revenue for the quarter was up 16.5% on a year-over-year basis. As a group, sell-side analysts predict that Progyny, Inc. will post 0.6 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Canaccord Genuity Group dropped their target price on shares of Progyny from $23.00 to $21.00 and set a "hold" rating on the stock in a research report on Monday, May 12th. BTIG Research raised shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price on the stock in a research report on Monday, March 31st. Finally, Bank of America boosted their price target on shares of Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a report on Tuesday, February 11th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $23.45.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.